DESC:FIELD OF INVENTION
[001] The field of invention generally relates to a wearable smart device, and more specifically, the field of invention relates to a system and method for a wearable smart device for monitoring withdrawal symptoms.

BACKGROUND
[002] Alcoholism is defined as an addiction or severe dependency on alcoholic beverages, and poses a serious threat to individuals having such a problem. The risk factors of alcoholism include acute mental health problems, genetic predisposition, morbidity and mortality. Therefore, it is essential that alcoholism be treated as soon as it is detected.
[003] However, treatment of alcoholism is problematic, and typically includes alcohol detoxification to withdraw the alcoholic individual from drinking or relying on alcohol, both physically and mentally. An individual undergoing such treatment may relapse, and hence, requires constant monitoring. Additionally, alcohol withdrawal can cause headaches, nausea, tremors, anxiety, hallucinations and seizure, and can be life-threatening if the symptoms are left untreated. Hence, in addition to monitoring the individual, it is also essential to monitor their vitals on a regular basis. This is necessary as the withdrawal process is physically demanding and the person’s vitals may spike or drop depending on the individual’s response to the withdrawal.
[004] Currently, existing systems for monitoring a patient are tedious and rely on people for round-the-clock monitoring. Another disadvantage is that current systems of detecting withdrawal are invasive as they require blood samples of the concerned individual to be drawn and transported carefully to pathology labs for testing. Further, such blood test reports will be available only after a considerable time, by time which the patient may suffer excessively. Such delays could pose a risk to their lives,
[005] Other existing systems are only configured to monitor vitals of an individual bear. Further, such systems offer a limited scope as do not monitor more than a few vital parameters of the individual. Thus, essential parameters may go undetected in such systems.
[006] Other existing systems that have tried to address these problems of monitoring such critical parameters viz., blood alcohol levels, etc., comprise heavy and sizable instruments which require a formal setup and pose a problem of portability. It is not possible to effectively monitor the concerned individual over long periods of timer by using such systems.
[007] Thus, in light of the above discussion, it is implied that there is need for a compact system and method for monitoring parameters of an alcoholic individual undergoing withdrawal treatment, which is reliable and does not suffer from the problems discussed above.
OBJECT OF INVENTION

[008] The principle object of this invention is to provide a system and method to monitor withdrawal symptoms in a user.
[009] A further object of the invention is to provide a compact and portable system to continually monitor biomarker levels in a user.
[0010] A further object of the invention is to monitor behavioral changes in a user undergoing a withdrawal process.
[0011] Another object of the invention is to store bio-markers for each user in a server.
[0012] Another object of the invention is to communicate alerts and real-time data of the user’s biomarker levels to the user’s designated contacts.

BRIEF DESCRIPTION OF FIGURES

[0013] This invention is illustrated in the accompanying drawings, throughout which, like reference letters indicate corresponding parts in the various figures.
[0014] The embodiments herein will be better understood from the following description with reference to the drawings, in which:
[0015] Figure 1 depicts/illustrates a smart wearable device, in accordance with an embodiment of the invention;
[0016] Figure 2(a) depicts/illustrates a front view of the smart wearable device, in accordance with an embodiment of the invention;
[0017] Figure 2(b) depicts/illustrates inner components of the smart wearable device, in accordance with an embodiment of the invention;
[0018] Figure 2(c) depicts/illustrates a side view of the smart wearable device, in accordance with an embodiment of the invention;
[0019] Figure 2(d) depicts/illustrates a diagonal view of the smart wearable device, in accordance with an embodiment of the invention;
[0020] Figure 3 depicts/illustrates the smart wearable device in communication with a server and a personal device of a designated contact, in accordance with an embodiment of the invention;
[0021] Figure 4 illustrates a method for monitoring alcohol withdrawal symptoms in a user, in accordance with an embodiment of the invention.

STATEMENT OF INVENTION
[0022] The present invention discloses a system and method for non-invasive monitoring of alcohol withdrawal symptoms in a user. The system comprises a smart wearable device, wherein the smart wearable device is a smart band that is worn on a user’s arm. The smart device comprises a plurality of biomarker level sensors wherein the plurality of sensors monitor biomarker levels such as blood alcohol level, blood pressure, anxiety, tremors, and heart rate. A server present in the system comprises a vitals comparison module for comparing the monitored biomarker levels to predetermined threshold levels. Based on a result of comparison, the server alerts an entity or a person related to the user through a personal device comprised in the system.
[0023] The smart device comprises a near-infrared (NIR) spectroscope to monitor alcohol level in the user’s bloodstream, an optical sensor configured to monitor the blood pressure of the user wearing said device, a pulse oximeter configured to measure the heart rate of the user at different times during the day and an EMG sensor configured to detect the minute electric signals generated by the user’s muscles, to monitor neuropathy in the user.

DETAILED DESCRIPTION

[0024] The embodiments herein and the various features and advantageous details thereof are explained more fully with reference to the non-limiting embodiments that are illustrated in the accompanying drawings and/or detailed in the following description. Descriptions of well-known components and processing techniques are omitted so as to not unnecessarily obscure the embodiments herein. The examples used herein are intended merely to facilitate an understanding of ways in which the embodiments herein may be practiced and to further enable those of skill in the art to practice the embodiments herein. Accordingly, the examples should not be construed as limiting the scope of the embodiments herein.
[0025] The present invention discloses, by way of an illustrative embodiment, a system for monitoring withdrawal symptoms in a user, comprising a smart wearable device. The disclosed system is capable of continually monitoring the user wearing the smart wearable device for withdrawal symptoms, determining a spike or plunge in said symptoms, and based on such a determination, alerting designated contacts of the user for further actions.
[0026] According to the present invention, withdrawal symptoms in a user may occur due to withdrawal from addiction to any substance including, but not limited to, narcotic drugs, alcohol, etc. In the scope of the present invention, a user may be any person or individual addicted to the practice of consuming alcoholic beverages or using narcotic drugs and the like, and who may be under the process of withdrawal from such an addiction.
[0027] The smart wearable device disclosed in the present invention is configured to monitor withdrawal symptoms in users undergoing withdrawal for one or more of alcohol addiction, drug addiction and the like. For the purpose of the present invention, the disclosed smart wearable device is used to detect withdrawal symptoms in a user undergoing a withdrawal process for alcohol addiction.
[0028] The present invention discloses a system comprising a smart wearable device configured to monitor withdrawal symptoms in a user by monitoring biomarkers of the user. This objective of monitoring biomarkers of a user is achieved by a plurality of sensors and processors present in the disclosed withdrawal monitoring system.
[0029] In the context of the present invention, biomarkers are biological measures of a biological state of an individual. A person skilled in the art will realize that a biomarker is a physical characteristic that is measured and evaluated as an indicator of person’s normal biological process.
[0030] Throughout this description, a comprehensive method for monitoring withdrawal symptoms in an individual has been explained with the help of an exemplary embodiment of a smart wearable device that is worn by the user. This exemplary embodiment of said device should not be read as a limitation of this invention, and the scope of this description covers other embodiments wherein the disclosed system comprising a smart wearable device configured to monitor withdrawal symptoms in a user may be utilized.
[0031] Referring now to the drawings, where similar reference characters denote corresponding features consistently throughout the figures, there are shown preferred embodiments.
[0032] Figure 1 depicts an environment 100 illustrating a user wearing a smart wearable device 102, in accordance with an embodiment of the invention.
[0033] As depicted in Figure 1, the smart wearable device 102 is adaptable to be worn on a user’s arm in such a way that the smart wearable device 102 is in direct epidermal contact with the user.
[0034] In an embodiment of the invention, the smart wearable device 102 is a smart band that can be worn on the arm of a user.
[0035] In other embodiments of the present invention, the smart band may be worn on the user’s feet or externally on other parts of the body. The smart wearable device 102, in such an embodiment, may be structurally designed in a different form, not limited to a smart band structure.
[0036] Alcohol is commonly known to harm an individual biologically by inducing mental disturbance, severe damage to internal organs, and creating a dependency of the user on alcohol. Withdrawal from such a dependency may further create more problems for the user, depending on the user’s bodily response to the withdrawal process. Symptoms of such withdrawal include light to extreme tremors in the user’s body, sudden plunge or spike in blood pressure, aperiodic palpitations, and the like.
[0037] In an event where the withdrawal process comprises monitoring the user over a period of time, it is also necessary that the blood alcohol levels be monitored and maintained in order to prevent any further damage to the user’s physiology.
[0038] The smart wearable device 102 disclosed in the present invention is configured to monitor the abovementioned biomarker levels of the user wearing said device. Such biomarkers comprise biological parameters such as, but not limited to, blood pressure, blood alcohol level, heart rate and neuropathy. A person skilled in the art will realize that neuropathy may be used to define dysfunction of one or more nerve cells that may result in numbness, muscle weakness, muscle dysfunction, and pain in the affected area.
[0039] The smart wearable device 102 is non-intrusive and light-weight in nature, thus enabling the user to wear said device at all times. In a preferred embodiment of the invention, the smart wearable device 102 continually monitors the user’s biomarker levels periodically, wherein the period may be pre-set in said device.
[0040] In an embodiment, such a period may either be a period of half an hour or a period of one hour. In other embodiments of the invention, this period may vary based on the user’s preferences and can be altered through a user interface on the smart wearable device 102 or a server (not shown in figure).
[0041] The smart wearable device 102 may be worn by the user similar to any sports sweatbands commonly known in the art.
[0042] The smart wearable device 102 may also comprise a battery module (not depicted in the figure) allowing said device 102 to monitor the user’s biomarker levels without interruption. The battery module may require charging as is known in the art.
[0043] Further, the monitored biomarker levels are compared to a set of predetermined biomarker levels in a server (not depicted in Figure 1). Based on a result of the comparison, a designated person or persons related to the user may be notified of a sudden spike or plunge in the biomarker levels, thus allowing the concerned persons to take a necessary course of action. The designated person may be a family member, friend or guardian of the user whose bio-markers are being monitored.
[0044] In an embodiment of the present invention, the smart wearable device 102 may be interfaced with a mobile application disposed on a smartphone or a smart device of the user and/or the designated person. Pre-requisite data points such as physiological information of the user may be entered into the mobile application to configure one or more functions of the smart wearable device 102 to meet the requirements of the user. In particular, a personalized user profile may be generated for the user through the server and/or the mobile application.
[0045] In other embodiments, one or more provisions to input user data may be available on one or more of the server, smart wearable device 102 of the user and the smart wearable device 102 of the designated person.
[0046] The user data provided by the user may comprise elaborate information including, but not limited to, name, address, weight, gender, age, number of years of active alcohol consumption, active physiological disorders and diseases in the past or in the present, on-going medication, name and contact details of the designated person, and the like.
[0047] In a preferred embodiment of the invention, the user may also be able to provide information about current drinking habits, and impose self-restrictions on such habits in order to self-moderate alcohol consumption habits.
[0048] Figure 2(a) depicts/illustrates a front view of the smart wearable device 102 at 200, in accordance with an embodiment of the invention.
[0049] In the present invention, the smart wearable device 102, as describe in the foregoing description, is a smart wearable band adapted to be worn on the user’s arm. Therefore, Figure 2(a) depicts a front view of the smart wearable device 102 as depicted when worn on the user’s arm.
[0050] The smart wearable device 102 is designed to have an exposed top side (depicted in Figure 2(a)) and a concealed bottom side (depicted in Figure 2(b)) when worn by the user, wherein each side housing a plurality of elements.
[0051] The exposed top side depicted in Figure 2(a) discloses a digital display 202 that is configured to display information of the biomarker levels monitored by the smart wearable device 102. In an embodiment of the invention, the digital display 202 may be a touch screen allowing the user to toggle through different frames of data using finger gestures. The digital display 202 may be any digital screen commonly known in the art such as an LCD screen, LED screen and the like.
[0052] In another embodiment of the invention, the smart wearable device 102 may comprise one or more buttons (not shown in the figure) on said device 102. The buttons may enable the user to perform one or more functions such as turning on the digital display 202, selecting one or more options, and toggling between frames of data on the digital display 202.
[0053] Further, in a preferred embodiment, the smart wearable device 102 comprises a mic 206 on the exposed top side. The mic 206 may allow the user to control said device 102 using voice commands or to communicate with other devices/people. In other embodiments, the wearable smart device 102 may also be controlled using aforementioned buttons.
[0054] The smart wearable device 102 further comprises an external speaker 204 above the digital display 202. In other embodiments of the invention, the speaker 204 may be present below the digital display 202 or on either side of the smart wearable device 102. The speaker 204 may allow the user to hear one or more instructions or alerts or to communicate with other devices/people.
[0055] The external speaker 204 may be configured to achieve the commonly known objective of communicating in audio format. In a preferred embodiment, the external speaker 204 may be used in the process of controlling the smart wearable device 102 using audio commands. Advantageously, the provision of an external speaker 204 and mic 206 may be effective in allowing visually impaired users to efficiently use the smart wearable device 102.
[0056] Further, in addition to the aforementioned advantages, the external speaker 204 may also be used to report the monitored biomarker levels in an audio format.
[0057] Figure 2(b) depicts/illustrates inner components of the smart wearable device 102, in accordance with an embodiment of the invention.
[0058] The smart wearable device 102 when worn by the user turns the back view of the device 102 into a concealed bottom side as aforementioned.
[0059] In a preferred embodiment of the invention, the concealed bottom side of the smart wearable device comprises a guarded housing 208. The guarded housing 208 further comprises a plurality of sensors and a battery module configured to monitor a different biological marker of the user.
[0060] The smart wearable device 102 comprises a near-infrared (NIR) spectroscope 210 to monitor alcohol level in the user’s bloodstream. The near-infrared spectroscope 210 is a compact sensor comprised in the guarded housing 208 that is configured to detect blood alcohol level using near-infrared region of the electromagnetic spectrum. In an embodiment, a commonly known near-infrared spectroscope constructed on a PCB viz., Sparkfun AS7262 may be used, or a near-infrared spectroscope may be constructed on a PCB for use in the smart wearable device 102.
[0061] Alcohol levels in the blood stream may be detected by using a method of illumination, i.e., transmission and reflection of light and determination of alcohol levels based on wavelength of the reflected light wave, as different materials absorb different wavelength of light.
[0062] In an embodiment, an optical sensor 212 is comprised in the guarded housing 208 in the smart wearable device 102.
[0063] The optical sensor 212 is configured to monitor blood pressure of the user wearing said device 102. In a preferred embodiment, the optical sensor 212 is an optical infrared sensor.
[0064] The optical sensor 212 flashes infrared light on the user’s skin, and is further configured to analyze the reflected infrared light. Based on the analysis of the reflected light, the user’s blood pressure is effectively measured.
[0065] In an embodiment of the invention, the optical sensor 212 may also be an opto-mechanical sensor.
[0066] In a preferred embodiment, the guarded housing 208 comprised in the smart wearable device 102 further comprises a pulse oximeter 214.
[0067] The pulse oximeter 214 comprised in the present invention is configured to measure heart rate of the user at different times during the day. Such measurement of the user’s heart rate may be during frequent periods in a day, before and/or after alcohol consumption, before and/or after indulging in a physical activity, and during a period when the user is in a state of slumber. The pulse oximeter 214 comprised in the present invention may be a PhotoPlethysmoGram (PPG) oximeter used to measure PPG oximetry.
[0068] Further, in a preferred embodiment, the wearable device 102 comprises an EMG sensor 216. A primary function of the EMG sensor 216 is to monitor neuropathy in the user. Some of the major alcohol withdrawal symptoms are seizures, tremors, and numb or damaged muscles.
[0069] The EMG sensor 216 comprised in the present invention is configured to monitor neuropathy, including alcohol neuropathy, in a user by monitoring small electric signals generated by the muscles in a human body when said muscles are moved.
[0070] The EMG sensor 216 comprised in the present invention is configured to detect the minute electric signals generated by the user’s muscles, and is also configured to monitor the user in case no electric signals are generated.
[0071] Further, a preferred embodiment of the present invention comprises a data communication module 218 configured to transmit one or more monitored data to external devices such as a server. In an embodiment, the data communication module 218 may be a Bluetooth Low Energy (BLE) module or a Wifi module, and in another embodiment, the data communication module 218 may be any other communication module commonly known in the art.
[0072] In an embodiment of the present invention, the smart wearable device 102 may also be used as an Internet-of-Things (IoT) device configured to communicate data with multiple external devices.
[0073] Further, in a preferred embodiment, the smart wearable device 102 comprises an attachment unit 220. Said attachment unit 220 may be any attachment unit such as, but not limited to, a Velcro patch, a clip-on mechanism, a belt loop and the like.
[0074] The attachment unit 220 enables the smart wearable device 102 to be gripped onto the user’s arm in order to enable effective monitoring of the user’s biomarker levels.
[0075] Figure 2(c) depicts/illustrates a side view of the smart wearable device 102, in accordance with an embodiment of the invention.
[0076] In a preferred embodiment, the smart wearable device 102 is designed to fit snugly onto the user’s arm. As depicted at 200 in Figure 2(c), the smart wearable device 102 is slightly tapering towards one end and slightly widened towards a second end. This enables the snug fit of the smart wearable device 102 on the user’s arm.
[0077] In an embodiment where the smart wearable device 102 is adapted to be worn on any body part other than the user’s arm, the structure of said device 102 may be altered to fit the concerned body part.
[0078] Figure 2(d) depicts/illustrates a diagonal view of the smart wearable device 102 as seen from a bottom side of said device 102 towards a top side of the device 102, in accordance with an embodiment of the invention.
[0079] The guarded housing 208 is visible in Figure 2(d), and is placed in the concealed bottom side of the smart wearable device 102, below the digital display 202 present on the exposed top side of said device 102.
[0080] Figure 3 depicts an environment 300 illustrating the smart wearable device 102 in communication with a server 302 and a user device 304 of a designated person or persons, in accordance with an embodiment of the invention.
[0081] In a preferred embodiment, the smart wearable device 102 is connected to a server 302. Said connection may be established using the data communication module 218 comprised in the smart wearable device 102 and a data transceiver 306 comprised in the server 302.
[0082] In an embodiment of the invention, the connection may be an internet connection, or a Bluetooth connection and the like.
[0083] In a preferred embodiment, the data communication module 218 communicates one or more information of the monitored biomarkers to the server 302 in real time. The information is continually updated as frequently as the monitoring of the user’s biomarkers occurs in the smart wearable device 102.
[0084] On receiving the communicated information, a database module 310 stored the received information.
[0085] A vitals comparison module 308 comprised in the server 302 processes the received biomarkers levels. The processed biomarker levels are further compared by the vitals comparison module 308 with predetermined threshold levels of biomarkers.
[0086] In an embodiment of the invention, the predetermined threshold levels of biomarkers are stored in a database module 310 in the server 302.
[0087] The predetermined threshold levels may be determined based on the user information entered in the user profile, thereby making said threshold levels customizable according to each user. In another embodiment, the predetermined threshold levels may be set based on the biomarker levels of an average healthy individual based on factors such as gender, age group, amount of alcohol consumption.
[0088] As aforementioned, the withdrawal process is physically demanding and biomarker levels of the user may spike or plunge depending on the individual’s bodily response to the withdrawal process. In such situations, the user’s heart rate may spike, or blood pressure may fall rapidly. In other situations, the electrical charge generated in the user’s muscles may be extremely feeble and lower than the predetermined threshold level, thereby indicating a numbed or a dysfunctional muscle.
[0089] In an embodiment of the invention, if the result of comparison of the monitored biomarker levels and the predetermined biomarker levels indicate an undesirable spike or plunge in said levels, the designated person or designated persons may be alerted through their user device 304.
[0090] The server 302 is configured to transmit such an alert to the user device 304 of a designated person. In an embodiment, the designated person’s user device 304 comprises a software application, wherein the software application interface in the user’s smartphone is different from the application interface in the designated person’s user device 304.
[0091] Said alert may be a push notification, or a method of displaying compared information on the mobile application on the designated person’s user device 304. In other embodiments, based on the variations of the result of comparison, the notifications may be more urgent such as audio notification or vibration of the personal device 304. The mobile application comprised in the designated person’s personal device 304 may alert the designated person if the user requires emotional assistance to abstain from alcohol consumption.
[0092] In an embodiment of the invention, one or more contact information of the designated person is stored in the database module 310 comprised in the server 302.
[0093] In certain embodiments of the invention, the designated person may also be alerted if the user’s alcohol consumption exceeds the self-restricted limits of consumption.
[0094] In a further embodiment, the designated person may be more than one person or maybe a group of persons associated with the user. In certain embodiments, the contact of designated person may be accompanied by contacts of a rehabilitation entity or a medical entity that the user may be associated with.
[0095] In an event where rehabilitation or a medical entity is also one of the designated contacts, the information of undesirable spikes or plunges in the user’s biomarker levels may be communicated to said entities in order to decide a further course of action for the user.
[0096] Figure 4 illustrates a method for monitoring alcohol withdrawal symptoms in a user, in accordance with an embodiment of the invention.
[0097] Initially, as depicted at 402, a smart wearable device is configured to a user and is strapped on an arm of the user for continually monitoring withdrawal symptoms in the user. As aforementioned in the foregoing description, in other embodiments of the invention, the smart wearable device may also be configured to be worn externally on other parts of the body of the user. Further, at step 404, a plurality of sensors present in the smart wearable device monitors various biomarker levels of the user wearing the said device. In a preferred embodiment of the invention, the various biomarkers monitored by the smart wearable device comprise one or more of blood pressure, heart rate, blood alcohol level and the kind.
[0098] Subsequently, at step 406, one or more monitored data of the biomarker levels is transmitted from the smart wearable device to a server present in the disclosed system. On receiving the transmitted data, a vitals comparison module present in the server processes the data and compares the received data to the data of predetermined threshold levels stored in the server, as depicted at step 408.
[0099] A data storage module present in the server stores one or more of the received data, the data processed and compared by the vitals comparison module, as well as the result of comparison, as depicted at step 410.
[00100] Thereafter, at step 412, based on the result of comparison of the received data to the predetermined threshold levels, the user’s designated contact or contacts are alerted through a personal device belonging to the designated contact or contacts. Such an alert may be generated if a spike or a plunge in the biomarker levels of the user is determined by the smart wearable device.
[00101] The present invention is advantageous since the present invention effectively monitors vital parameters and biomarkers of the user in a non-invasive manner.
[00102] The disclosed system is further advantageous in a way that said system is comprehensive in nature and is capable of independently monitoring more than one critical parameter or biomarker for a user undergoing a withdrawal process. The disclosed system can successfully monitor several biomarkers simultaneously error-free in real time.
[00103] Another advantage of the present invention is that it is non-intrusive and compact in nature. Such a convenient system allows the user to wear the smart wearable device at all times, thereby allowing more efficient monitoring of his biomarker levels.
[00104] The present invention, as aforementioned is non-intrusive and light-weight in nature. Once the smart wearable device is strapped on the body of the user, the user may also travel from one place to another, and be monitored for symptoms, therefore making the disclosed system more competent and dynamic.
[00105] Moreover, the compactness of the sensors comprised in the smart wearable device allows said device to be economical in nature, thereby making the disclosed system cost-effective.
[00106] Further advantages of the current invention include the provision of alerting a person or a group of persons related to the user in an event where a spike or a plunge in the biomarker levels may be detected for the user.
[00107] In a further advantage of the present invention, the smart wearable device comprised in the system can also be used as an IoT device, wherein if connected to a network, data from said device can be disseminated to and aggregated on other user devices or other personal devices. Such a provision results in a further advantage wherein the user’s information of biomarker levels can be utilized by rehabilitation centers or medical organizations to study further and take necessary actions.
[00108] The present invention can be effectively used in monitoring alcohol withdrawal symptoms in a user. However, the scope of the present invention is not limited to monitoring alcohol withdrawal symptoms and may be similarly used in monitoring such withdrawal symptoms in other users undergoing withdrawal processes for different addictions such as drug addiction, nicotine addiction and the like.
[00109] In an event where the smart wearable device comprised in the present invention is used in monitoring withdrawal symptoms in a user addicted to nicotine, an additional sensor may be added or an existing sensor replaced in order to monitor a different biomarker of the user, for example, blood oxygen level sensor.
[00110] Therefore, the present invention can be effectively used in monitoring withdrawal symptoms for various addictions of users with a few structural modifications. In some embodiments of such an application of the present invention, structural modifications or replacement of sensors may not be necessary, and the present invention may be used to detect withdrawal symptoms for various different addictions.
[00111] The foregoing description of the specific embodiments will so fully reveal the general nature of the embodiments herein that others can, by applying current knowledge, readily modify and/or adapt for various applications such specific embodiments without departing from the generic concept, and, therefore, such adaptations and modifications should and are intended to be comprehended within the meaning and range of equivalents of the disclosed embodiments. It is to be understood that the phraseology or terminology employed herein is for the purpose of description and not of limitation. Therefore, while the embodiments herein have been described in terms of preferred embodiments, those skilled in the art will recognize that the embodiments herein can be practiced with modification within the scope of the embodiments as described here.

,CLAIMS:We claim:
1. A system for monitoring withdrawal symptoms in a user, comprising:
a smart wearable device (102) for monitoring and communicating at least one biological marker of the user;
at least one user device (304) for communicating an alert to a designated person; and
a server (302) in communication with the smart wearable device (102) and the at least one user device (304), wherein the server (302) is configured to process the monitored at least one biological marker and transmit an alert to the at least one user device (304) based on the processed at least one biological marker.

2. The system as claimed in claim 1, wherein the smart wearable device 102 comprises a plurality of sensors for monitoring the at least one biological marker of the user, wherein the plurality of sensors comprise one or more of:
a pulse oximeter (214) configured to measure heart rate of the user;
an optical sensor (212) configured to monitor blood pressure of the user wearing said device (102);
a near-infrared (NIR) spectroscope 210 to monitor an alcohol level in the user’s bloodstream; and
an EMG sensor (216) configured to detect minute electric signals generated by the user’s muscles, to monitor neuropathy in the user.

3. The system as claimed in claim 1, wherein the server (302) comprises a vitals comparison module (308) to process the monitored biomarker levels; and wherein the processed biomarker levels are compared with predetermined threshold levels of biomarkers to determine whether to transmit an alert to the at least one user device (304).

4. The system as claimed in claim 1, wherein the smart wearable device (102) comprises a digital display (202) configured to display information of the monitored at least one biomarker levels, and at least one button for providing inputs to the smart wearable device (102).

5. The system as claimed in claim 1, wherein the smart wearable device (102) comprises:
a mic (206) for enabling the user to control the smart wearable device (102) using voice commands or to communicate with the user device (304);
and a speaker (204) for enabling the user for one or more of hearing one or more instructions / alerts / reporting the monitored biomarker levels, and communicating with the user device (304).

6. A method for monitoring withdrawal symptoms in a user, comprising:
monitoring at least one biological marker of the user by using a smart wearable device (102);
communicating the at least one biological marker of the user to a server (302);
processing the monitored at least one biological marker, by using the server (302); and
determining whether to transmit an alert to an at least one user device (304) based on the processed at least one biological marker; and
transmitting the alert to the at least one user device (304).

7. The method as claimed in claim 7, comprising:
measuring a heart rate of the user by using a pulse oximeter (214);
an optical sensor (212) configured to monitor blood pressure of the user wearing said device (102);
monitoring an alcohol level in the user’s bloodstream by using a near-infrared (NIR) spectroscope (210); and
detecting minute electric signals generated by the user’s muscles to monitor neuropathy in the user, by using an EMG sensor (216).

8. The method as claimed in claim 7, wherein processing the monitored at least one biological marker comprises:
processing the monitored biomarker levels;
comparing the processed biomarker levels with predetermined threshold levels of biomarkers, by using a vitals comparison module (308).

9. The method as claimed in claim 7, comprising:
displaying information of the monitored at least one biomarker levels by using a digital display (202); and
providing inputs to the smart wearable device (102) at least one button.

10. The method as claimed in claim 7, comprising:
providing voice commands or communicating with the user device (304), by using a mic (206); and
providing instructions/ alerts / reporting the monitored biomarker or communicating with the user device (304), by using a speaker (204).

Date: 14th May, 2020 Signature:
Name of signatory: Nishant Kewalramani
(Patent Agent for the Applicant)
IN/PA number: 1420